As Swedish contract manufacturer APL reforms the organization 75 staff members are being made redundant.
The company’s new ambition is, according to a recent press release, profile APL towards a more customer oriented business. The different businesses areas will be refined and manufacturing and delivery will be synchronized. The new organization will come into effect on March 15, when 75 employees also will have to leave their posts.
“The surrounding world is changing and we have to change with it in order to continue as a leading company within extempore and drug development on contract basis. Our client focus and businesslikeness need constant progress,” says Eva Sjökvist Saers, APL CEO in a press release.
APL has sites in Gothenburg, Malmö, Stockholm and Umeå which will all remain. The most important restructure will be a division of the organization into three different unities; Purchase, Logistics & IT, Extempore and Production & Development.
Since 2010, APL is a separate company owned by the Swedish state. It was previously a company within the Apoteket AB group. At the turn of the year 2011/2012 the company had a total of 448 staff members. In December 2012, APL inaugurated a new production site in Kungens Kurva, in the southern parts of Stockholm. The company had received a contract to deliver cytostatic and extempore drugs to the Stockholm County Council through the unit at Karolinska University Hospital in Solna.